Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Indian law could choke cheap drug supply

Nature Medicine volume 11, page 460 (2005)Cite this article

Access through your institution
Buy or subscribe

Activists say law will make HIV/AIDS drugs unaffordable for most people.

The Indian government has passed a new law forbidding local companies from manufacturing copies of drugs patented elsewhere. Although last-minute changes to its wording loosened many restrictions, critics say the law will eventually raise the cost of generic drugs for millions of people in developing countries.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Hyderabad

    K.S. Jayaraman

Authors
  1. K.S. Jayaraman
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

New patent rules drive Indian drug firms to research

Drive for patent-free innovation gathers pace

http://www.nature.com/news/specials/aids/index.html

Related external links

World Trade Organization

Médecins Sans Frontières

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jayaraman, K. Indian law could choke cheap drug supply. Nat Med 11, 460 (2005). https://doi.org/10.1038/nm0505-460b

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0505-460b

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing